Catalyst Wire Dossier Catalyst Wire Dossier

Candesartan Cilexetil and Hydrochlorothiazide

Candesartan cilexetil and hydrochlorothiazide · ANI Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

19 regulatory and trial events tracked for Candesartan Cilexetil and Hydrochlorothiazide, covering 2006-08-17 to 2021-05-13. Get the full timeline:

Most recent: FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)

See pricing